His clinical and research interests include the underlying pathophysiology of basal ganglia disorders. The present focus of Dr. Albin's research is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. Molecular imaging with Positron Emission Tomography (PET) methods is a primary research tool. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.

A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Neurology and Movement Disorders. He is a Fellow of the American Association for the Advancement of Science and the 2021 recipient of the American Academy of Neurology Movement Disorders Research Award.